| Ticker: | ITRM |
| Current Price: | $0.03 |
| % Daily Change: | -10.98% |
| Volume (1,000s): | 49,297.94 |
| Average Volume (1,000s): | 16,325.92 |
| Market Cap (M): | $1.60 |
Iterum Therapeutics plc
Fitzwilliam Court
1st Floor Leeson Close
Dublin, D02 YW24
Ireland
U.S. Operations
200 S Wacker Drive
Suite 3100
Chicago, IL 60606
Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. For more information on Iterum Therapeutics please visit www.iterumtx.com.